Drug makers reach patent accord over Plavix
Sanofi-Aventis and its partner Bristol-Myers Squibb have said they tentatively settled a patent dispute involving Plavix, the anti-clotting agent that is the world's second-best-selling drug. The
Sanofi-Aventis and its partner Bristol-Myers Squibb have said they tentatively settled a patent dispute involving Plavix, the anti-clotting agent that is the world's second-best-selling drug. The